I've been checking my Hargreaves Lansdown SIPP every couple of hours for the last three days after receiving confirmation on Saturday that Legal & General had completed my transfer request.
I was muttering darkly about the delay, but began to formulate a new plan last night.
My original plan was a split between CEY:Centamin and VRS:Versarien, but then the VRS:Versarien share price went bonkers and there was no way I was paying 125p a share. Instead I was just celebrating my recent purchase being 25% up already.
I re-formulated my plan to put it all into CEY:Centamin, which I feel is still massively undervalued and would enable me to average down. There's also a dividend ex-date looming so I would have got about £30 extra dividends.
However, last night OPTI:Optibiotix slipped below 80p. Granted, the average price in my SIPP is 67p, so buying at this price would increase the average, but with all the great news out recently and the promise of even greater news to come, I was wavering.
The reason I was wavering is I'm massively overweight in OPTI:Optibiotix already. In the interest of a diversified portfolio, surely it would be mad to invest even more?
This morning the price dropped again. I couldn't believe it. When the transfer finally arrived just after lunch, I tried a speculative order for OPTI:Optibiotix to see how cheap it would be. When the answer came as 78.399p I hit the buy button without hesitating. That bought me another 2,790 shares and cost £2,199.28. The effect on my average SIPP price wasn't too bad, raising from 67p to 68.1p.
Normally when I buy something I can pretty much guarantee it will drop immediately.
Not this time!
A big buy sent the share price up to a bid price of 83p by the end of the day.
That doesn't normally happen!
So where does that leave my OPTI:Optibiotix holding?
Altogether I have 82,667 shares bought at average of 66.9p costing a total, when commission is added, of £55,615.82. That's a sightly shocking £310 of commission.
They are currently up around 25% making paper profit of £12,961.94 but as far as I'm concerned things haven't even started yet.
Given that each 1p rise in share price is now worth £826.67 it will have even more of an impact on my portfolio than it did before, even with small rises.
If we can get back to 130p, which VRS:Versarien nearly did the other day from similar levels, that would whack up my paper profits to £51,815.43.
I honestly believe that could happen in a matter of days after a big RNS for Sweetbiotix confirming a global contract. As sweetbiotix is miles ahead of any of the competition, it's not a question of "if" a global contract is signed, but "when".
I'm always very excited about OPTI:Optibiotix, but now more than ever.
No comments:
Post a Comment